EXOC3L2
Basic information
Region (hg38): 19:45212370-45245407
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EXOC3L2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 17 | ||||
missense | 46 | 53 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 3 | ||||
non coding | 9 | |||||
Total | 0 | 1 | 47 | 20 | 12 |
Variants in EXOC3L2
This is a list of pathogenic ClinVar variants found in the EXOC3L2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-45213075-C-G | not specified | Uncertain significance (Jun 07, 2023) | ||
19-45213082-C-T | not specified | Uncertain significance (Dec 19, 2022) | ||
19-45213088-C-T | Uncertain significance (Sep 27, 2022) | |||
19-45213090-C-T | Benign (Jul 07, 2023) | |||
19-45213099-C-T | Likely benign (Jan 24, 2024) | |||
19-45213106-C-T | Benign (Jan 22, 2024) | |||
19-45213107-G-A | not specified | Uncertain significance (Mar 29, 2022) | ||
19-45213112-C-T | Uncertain significance (May 01, 2023) | |||
19-45213113-G-A | Uncertain significance (Nov 03, 2023) | |||
19-45213131-T-C | Benign (Jul 17, 2023) | |||
19-45213150-G-T | Likely benign (Oct 03, 2023) | |||
19-45213152-G-C | not specified | Uncertain significance (Jan 23, 2024) | ||
19-45213202-G-A | not specified | Uncertain significance (May 02, 2024) | ||
19-45213209-G-C | not specified | Uncertain significance (Feb 27, 2024) | ||
19-45213213-G-T | EXOC3L2-related disorder | Likely benign (Sep 21, 2023) | ||
19-45213217-G-A | not specified | Uncertain significance (Dec 05, 2022) | ||
19-45213263-A-G | Benign/Likely benign (Dec 01, 2022) | |||
19-45213280-G-A | not specified | Uncertain significance (Mar 16, 2024) | ||
19-45213284-C-T | not specified | Uncertain significance (Sep 07, 2022) | ||
19-45213290-G-C | not specified | Uncertain significance (Sep 14, 2022) | ||
19-45213302-G-A | Uncertain significance (Jul 19, 2022) | |||
19-45213316-C-T | not specified | Uncertain significance (Oct 10, 2023) | ||
19-45213332-C-T | not specified | Uncertain significance (Jan 08, 2024) | ||
19-45213347-C-T | not specified | Uncertain significance (Aug 15, 2023) | ||
19-45216091-C-T | not specified | Uncertain significance (Dec 14, 2021) |
GnomAD
Source:
dbNSFP
Source:
Intolerance Scores
- loftool
- 0.0841
- rvis_EVS
- -0.16
- rvis_percentile_EVS
- 42.06
Haploinsufficiency Scores
- pHI
- 0.106
- hipred
- N
- hipred_score
- 0.419
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.210
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Exoc3l2
- Phenotype
- immune system phenotype; skeleton phenotype; liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); craniofacial phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- exocytosis;biological_process;exocyst localization
- Cellular component
- exocyst;cellular_component
- Molecular function
- SNARE binding;molecular_function